Ideaya Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Ideaya Biosciences
IDYA Stock  USD 18.47  0.66  3.45%   
Ideaya Biosciences financial statements provide useful quarterly and yearly information to potential Ideaya Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ideaya Biosciences financial statements helps investors assess Ideaya Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ideaya Biosciences' valuation are summarized below:
Gross Profit
-287.7 M
Market Capitalization
1.7 B
Enterprise Value Revenue
145.3489
Revenue
7 M
Earnings Share
(3.36)
We have found one hundred twenty available fundamental trends for Ideaya Biosciences, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Ideaya Biosciences regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 2.2 B. The current year's Enterprise Value is expected to grow to about 2.1 B

Ideaya Biosciences Total Revenue

6.65 Million

Check Ideaya Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ideaya Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 55.1 M, Interest Income of 55.1 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 315, Dividend Yield of 0.0 or PTB Ratio of 2.08. Ideaya financial statements analysis is a perfect complement when working with Ideaya Biosciences Valuation or Volatility modules.
  
Check out the analysis of Ideaya Biosciences Correlation against competitors.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.

Ideaya Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.2 B1.1 B273.2 M
Slightly volatile
Other Current Liabilities31.6 M30.1 M9.2 M
Slightly volatile
Total Current Liabilities28 M46.1 M15.5 M
Slightly volatile
Other Liabilities5.7 M6 M7.7 M
Slightly volatile
Property Plant And Equipment Net29.1 M27.7 M8.6 M
Slightly volatile
Accounts Payable16.2 M15.4 M3.3 M
Slightly volatile
Cash73.5 M84.4 M40.6 M
Slightly volatile
Non Current Assets Total456.1 M434.4 M75.9 M
Slightly volatile
Non Currrent Assets Other427 M406.6 M52.4 M
Slightly volatile
Other Assets239.2 K184.5 K221.4 K
Pretty Stable
Cash And Short Term Investments710.1 M676.3 M202 M
Slightly volatile
Common Stock Shares Outstanding85.8 M81.7 M29.7 M
Slightly volatile
Short Term Investments621.5 M591.9 M152.2 M
Slightly volatile
Long Term Debt Total2.6 M2.9 M3.1 M
Slightly volatile
Liabilities And Stockholders Equity1.2 B1.1 B273.2 M
Slightly volatile
Non Current Liabilities Total29.9 M18.9 M34 M
Pretty Stable
Capital Surpluse709.7 M675.9 M222.7 M
Slightly volatile
Other Current Assets14.1 M13.4 M3.7 M
Slightly volatile
Other Stockholder Equity1.8 B1.7 B368.3 M
Slightly volatile
Total Liabilities61.7 M64.9 M109.2 M
Slightly volatile
Property Plant And Equipment Gross41.4 M39.5 M11.2 M
Slightly volatile
Total Current Assets724.2 M689.7 M197.3 M
Slightly volatile
Non Current Liabilities Other7.7 M7.8 M4.1 M
Slightly volatile
Net Working Capital675.8 M643.6 M180.5 M
Slightly volatile
Common Stock9.4 K9 K3 K
Slightly volatile
Property Plant Equipment7.2 M7.5 M5.4 M
Slightly volatile
Short and Long Term Debt Total20.1 M19.2 M7.8 M
Slightly volatile
Current Deferred Revenue19.3 M9.9 M9.6 M
Slightly volatile
Net Receivables2.9 K3 K1.4 M
Slightly volatile

Ideaya Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income55.1 M52.5 M8.7 M
Slightly volatile
Interest Income55.1 M52.5 M8.7 M
Slightly volatile
Depreciation And Amortization4.8 M4.6 M1.5 M
Slightly volatile
Selling General Administrative19.7 M39.3 M11.1 M
Slightly volatile
Other Operating Expenses350.7 M334 M80.3 M
Slightly volatile
Research Development309.4 M294.7 M67.9 M
Slightly volatile
Total Operating Expenses350.7 M334 M80.3 M
Slightly volatile
Reconciled Depreciation2.1 M3.8 M1.3 M
Slightly volatile
Total Other Income Expense Net55.1 M52.5 M9.8 M
Slightly volatile
Non Operating Income Net Other4.6 M4.4 M1.7 M
Slightly volatile

Ideaya Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock64.4 M101.6 M45.5 M
Slightly volatile
Stock Based Compensation36.5 M34.7 M7.3 M
Slightly volatile
Begin Period Cash Flow165.7 M157.8 M43.4 M
Slightly volatile
Other Cashflows From Financing Activities20.5 M23.3 M21.8 M
Very volatile
Depreciation2.1 M3.8 M1.3 M
Slightly volatile
Capital Expenditures2.4 M3.9 M2 M
Slightly volatile
Total Cash From Financing Activities711.4 M677.6 M151.2 M
Slightly volatile
End Period Cash Flow73.8 M85.2 M40.8 M
Slightly volatile
Issuance Of Capital Stock696.8 M663.6 M181.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio31530058.8582
Slightly volatile
Days Sales Outstanding0.150.156425.1391
Slightly volatile
Stock Based Compensation To Revenue5.214.96370.845
Slightly volatile
Capex To Depreciation1.741.0062.8643
Slightly volatile
EV To Sales30529154.6803
Slightly volatile
Payables Turnover0.660.73.2526
Pretty Stable
Sales General And Administrative To Revenue5.95.61461.4038
Slightly volatile
Research And Ddevelopement To Revenue44.242.09617.3765
Slightly volatile
Capex To Revenue0.580.5510.1045
Slightly volatile
Cash Per Share5.688.28034.3102
Slightly volatile
Days Payables Outstanding367541528
Slightly volatile
Net Debt To EBITDA0.190.19940.5714
Slightly volatile
Current Ratio9.6214.97079.05
Slightly volatile
Receivables Turnover2.5 K2.3 K404
Slightly volatile
Capex Per Share0.07930.04720.095
Slightly volatile
Revenue Per Share0.08140.08570.7055
Slightly volatile
Interest Debt Per Share0.230.23470.226
Pretty Stable
Debt To Assets0.01620.01710.1044
Slightly volatile
Days Of Payables Outstanding367541528
Slightly volatile
Ebt Per Ebit1.00.83940.878
Slightly volatile
Quick Ratio9.9114.97079.2524
Slightly volatile
Net Income Per E B T0.750.840.9067
Slightly volatile
Cash Ratio3.411.83152.8369
Pretty Stable
Days Of Sales Outstanding0.150.156425.1391
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.141.01561.0938
Slightly volatile
Fixed Asset Turnover0.240.25232.1777
Very volatile
Debt Ratio0.01620.01710.1044
Slightly volatile
Price Sales Ratio31530058.8582
Slightly volatile
Asset Turnover0.00590.00620.0608
Slightly volatile

Ideaya Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.2 B2.1 B689.8 M
Slightly volatile
Enterprise Value2.1 B2 B648.8 M
Slightly volatile

Ideaya Fundamental Market Drivers

Forward Price Earnings4.649
Cash And Short Term Investments676.3 M

Ideaya Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ideaya Biosciences Financial Statements

Ideaya Biosciences stakeholders use historical fundamental indicators, such as Ideaya Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Ideaya Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ideaya Biosciences' assets and liabilities are reflected in the revenues and expenses on Ideaya Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ideaya Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue9.9 M19.3 M
Total Revenue7 M6.7 M
Cost Of Revenue4.6 M7.7 M
Stock Based Compensation To Revenue 4.96  5.21 
Sales General And Administrative To Revenue 5.61  5.90 
Research And Ddevelopement To Revenue 42.10  44.20 
Capex To Revenue 0.55  0.58 
Revenue Per Share 0.09  0.08 
Ebit Per Revenue(46.71)(44.38)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether Ideaya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ideaya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ideaya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ideaya Biosciences Stock:
How To Invest In Ideaya
Details
Is Ideaya Stock a good investment?
Details
What is Ideaya Biosciences' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Ideaya Biosciences Correlation against competitors.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.36)
Revenue Per Share
0.086
Quarterly Revenue Growth
0.785
Return On Assets
(0.23)
Return On Equity
(0.33)
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY